-
Neodzivnost na peroralno antiagregacijsko zdravljenje = Non-responsiveness to oral antiplatelet treatmentPerme, Rok ; Blinc, AlešBackground Antiplatelet treatment with aspirin and/or clopidogrel reduces the incidence of atherothrombotic events but does not abolish them altogether. ln a multifactorial pathological process such ... as atherothrombosis no single preventive strategy cart be completely successful, yet prescribing antiplatelet treatment without routinely measuring its efficacy raises concern. Results Several studies using different methods have shown that a substantial part of the population is non-responsive or semi-responsive to oral antiplatelet treatment. These people have a higher incidence of atherothrombotic events, such as myocardial infarction, ischemic stroke, worsening of limb ischemia or cardiovascular death. The main problem in assessing non-responsiveness to antiplatelet treatment is that laboratory methods in vitro can only roughly estimate the function of platelets in vivo. Currently, there is no consensus reither on standardized testing of platelet function or on clinical decisions based on testing but several clinical studies are addressing these issues. Conclusions Current clinical guidelines do not eecommend routine platelet function testing in patients on antiplateletmedication, but these guidelines may be revised in the future based on results of ongoing clinical studies.Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 75, št. 10, okt. 2006, str. 635-643)Vrsta gradiva - članek, sestavni delLeto - 2006Jezik - slovenskiCOBISS.SI-ID - 21992153
Avtor
Perme, Rok |
Blinc, Aleš
Teme
Platelet Aggregation Inhibitors |
Drug Resistance |
Platelet Function Tests |
Aspirin |
Cerebrovascular Disorders |
Aspirin |
Cerebrovaskularne motnje |
Trombociti, funkcijski testi |
Trombociti, zlepljenje, inhibitorji |
Zdravilo, rezistenca |
zdravila |
aspirin |
cerebrovaskularne motnje |
zdravljenje |
antiagregacijsko zdravljenje |
učinkovanje |
neodzivnost
![loading ... loading ...](themes/default/img/ajax-loading.gif)
vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 75, št. 10, okt. 2006, str. 635-643)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Perme, Rok | 32888 |
Blinc, Aleš | 07630 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi